These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19546529)

  • 1. Lack of association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients.
    Yeo Y; Byun SW; Lee JY; Min WK; Park JS; Kim SB
    Am J Nephrol; 2009; 30(3):310-4. PubMed ID: 19546529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
    Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
    J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
    Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
    Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in Arab patients with coronary heart disease.
    Akanji AO; Suresh CG; Fatania HR; Al-Radwan R; Zubaid M
    Metabolism; 2007 Apr; 56(4):484-90. PubMed ID: 17379005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
    Sharma R; Singh B; Mahajan M
    Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of coronary artery disease in nondiabetic hemodialysis patients: a matched case-control study.
    Zumrutdal A; Baltali M; Micozkadioglu H; Torun D; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):67-71. PubMed ID: 17365912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of small apolipoprotein (a) isoforms and small, dense LDL on coronary artery disease risk.
    Zeljkovic A; Bogavac-Stanojevic N; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Vekic J; Spasic S
    Arch Med Res; 2009 Jan; 40(1):29-35. PubMed ID: 19064124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.